Sophie R. Vaccarino, MD, MSc

  • 4Articles
  • 50.5KReads
  • 2019–2024Active
  • 11Collaborators
  • 61Citations

About

Sophie R. Vaccarino, MD, MSc, is affiliated with the Cumming School of Medicine at the University of Calgary, Alberta, Canada. Her publications from 2019 to 2024 focus on the cognitive effects of treatments in psychiatric conditions, including major depressive disorder, schizophrenia, and the impact of COVID. She has contributed systematic reviews on electroconvulsive therapy, ketamine, antidepressants, and modafinil, examining their procognitive effects. Frequent collaborators include Shane J. McInerney, Sidney H. Kennedy, and Venkat Bhat.

Publications

JCP
Cognitive Effects of ECT in Schizophrenia: A Review
Review Article

Cognitive Effects of ECT in Schizophrenia: A Review

June 5, 2024

ECT was not associated with any significant cognitive deficits in people with treatment-resistant schizophrenia across global cognition, attention, language, visuospatial function, and executive function domains. The majority of studies...
,
JCP
Systematic Review

Cognitive Effects of Ketamine in Depression

January 4, 2022

The cognitive effects of ketamine have not been thoroughly investigated in depressed populations. This systematic review sought to determine the objective neurocognitive effects of ketamine in individuals with unipolar...
, , , et al
JCP
Original Research

Procognitive Effects of Therapeutic Agents in MDD

July 21, 2020

What is the efficacy of antidepressants and other agents for treating cognitive impairment in adults with major depressive disorder? Review available research in this CME journal activity.
, ,
JCP
Review Article

Procognitive Effects of Modafinil in Depression

October 8, 2019

Depression can cause notable cognitive deficits. Read this review article to learn about the efficacy of the wakefulness-promoting drug modafinil in the treatment of cognitive impairments associated with major...
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe